The kappa B enhancer motifs in human immunodeficiency virus type 1 and simian virus 40 recognize different binding activities in human Jurkat and H9 T cells: evidence for NF-kappa B-independent activation of the kappa B motif - PubMed (original) (raw)

The kappa B enhancer motifs in human immunodeficiency virus type 1 and simian virus 40 recognize different binding activities in human Jurkat and H9 T cells: evidence for NF-kappa B-independent activation of the kappa B motif

W Phares et al. J Virol. 1992 Dec.

Abstract

The kappa B transcriptional enhancer motif, present in many viruses, is broadly active in many cell types. It is recognized by c-Rel/HIVEN86A in DNA affinity precipitation (DNAP) assays and by the Rel-related p50 and p65 subunits of the nuclear factor NF-kappa B in electrophoretic mobility shift assays (EMSA). We have analyzed activities that bind the human immunodeficiency virus type 1 and simian virus 40 kappa B motifs in two human leukemia cell lines, Jurkat and H9. In both DNAP and EMSA analyses of Jurkat cell extracts, we detected multiple kappa B motif-binding activities in addition to c-Rel/HIVEN86A and p50-p65 NF-kappa B. In Jurkat cell nuclear extracts, EMSA analysis revealed at least six specific DNA-protein complexes, of which one comigrated with the p50-p65 NF-kappa B complex. Formation of all six complexes was enhanced by stimulation of the cells with phorbol 12-myristate-13-acetate and phytohemagglutinin but was differentially affected by the salt concentration in the binding reaction and by the conditions of Jurkat cell growth. Nuclear extracts from both unstimulated and stimulated H9 cells revealed similar levels of five kappa B motif-specific complexes, all of which displayed mobilities distinct from those of the Jurkat cell complexes. Indeed, a complex corresponding to p50-p65 NF-kappa B was not detectable in nuclear extracts from unstimulated H9 cells although such a complex was apparent in nuclear extracts from stimulated H9 cells. In contrast to the inducibility of a p50-p65 NF-kappa B-like complex, transcriptional enhancers composed of multimerized kappa B motifs displayed similar high levels of activity in both the unstimulated and stimulated H9 cells. Thus, the activity of the kappa B motif in H9 cells corresponded to the abundance of the H9 cell-specific kappa B motif complexes and not to the levels of p50-p65 NF-kappa B complex. These results suggest that the broad activity of the kappa B enhancer element is not only due to the broadly distributed NF-kappa B activator but also to cell type-specific kappa B motif-binding activities.

PubMed Disclaimer

Similar articles

• Functional similarities between human immunodeficiency virus type 1 and simian virus 40 kappa B proto-enhancers.
  Phares W, Herr W. Phares W, et al. J Virol. 1991 May;65(5):2200-10. doi: 10.1128/JVI.65.5.2200-2210.1991. J Virol. 1991. PMID: 1850006 Free PMC article.
• NF-kappa B-dependent induction of the NF-kappa B p50 subunit gene promoter underlies self-perpetuation of human immunodeficiency virus transcription in monocytic cells.
  Paya CV, Ten RM, Bessia C, Alcami J, Hay RT, Virelizier JL. Paya CV, et al. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7826-30. doi: 10.1073/pnas.89.16.7826. Proc Natl Acad Sci U S A. 1992. PMID: 1502202 Free PMC article.
• The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences.
  Urban MB, Baeuerle PA. Urban MB, et al. New Biol. 1991 Mar;3(3):279-88. New Biol. 1991. PMID: 1878350
• The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
  Doerre S, Sista P, Sun SC, Ballard DW, Greene WC. Doerre S, et al. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1023-7. doi: 10.1073/pnas.90.3.1023. Proc Natl Acad Sci U S A. 1993. PMID: 8430069 Free PMC article.
• Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation.
  Arima N, Molitor JA, Smith MR, Kim JH, Daitoku Y, Greene WC. Arima N, et al. J Virol. 1991 Dec;65(12):6892-9. doi: 10.1128/JVI.65.12.6892-6899.1991. J Virol. 1991. PMID: 1719236 Free PMC article.

Cited by

• Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits.
  Brown AM, Linhoff MW, Stein B, Wright KL, Baldwin AS Jr, Basta PV, Ting JP. Brown AM, et al. Mol Cell Biol. 1994 May;14(5):2926-35. doi: 10.1128/mcb.14.5.2926-2935.1994. Mol Cell Biol. 1994. PMID: 8164652 Free PMC article.
• Constitutive and inducible kappa B binding activities in the cytosol of v-Rel-transformed lymphoid cells.
  Hodgson J, Enrietto PJ. Hodgson J, et al. J Virol. 1995 Mar;69(3):1971-9. doi: 10.1128/JVI.69.3.1971-1979.1995. J Virol. 1995. PMID: 7853544 Free PMC article.
• Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription.
  Kutsch O, Levy DN, Bates PJ, Decker J, Kosloff BR, Shaw GM, Priebe W, Benveniste EN. Kutsch O, et al. Antimicrob Agents Chemother. 2004 May;48(5):1652-63. doi: 10.1128/AAC.48.5.1652-1663.2004. Antimicrob Agents Chemother. 2004. PMID: 15105117 Free PMC article.
• DNA replication facilitates the action of transcriptional enhancers in transient expression assays.
  Wilson AC, Patient RK. Wilson AC, et al. Nucleic Acids Res. 1993 Sep 11;21(18):4296-304. doi: 10.1093/nar/21.18.4296. Nucleic Acids Res. 1993. PMID: 8414985 Free PMC article.
• Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression.
  Abdulkadir SA, Krishna S, Thanos D, Maniatis T, Strominger JL, Ono SJ. Abdulkadir SA, et al. J Exp Med. 1995 Aug 1;182(2):487-500. doi: 10.1084/jem.182.2.487. J Exp Med. 1995. PMID: 7629508 Free PMC article.

References

1. 1. EMBO J. 1991 Jul;10(7):1817-25 - PubMed
2. 1. Biochim Biophys Acta. 1991 Apr 16;1072(1):63-80 - PubMed
3. 1. Genes Dev. 1990 Nov;4(11):1975-84 - PubMed
4. 1. Cell. 1990 Sep 7;62(5):1007-18 - PubMed
5. 1. Cell. 1990 Sep 7;62(5):841-3 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Research Materials

  • NCI CPTC Antibody Characterization Program